Quality assurance of radiation therapy after breast-conserving surgery among patients in the BOOG 2013-08 trial

In patients with clinically node-negative (cN0) breast cancer a sentinel lymph node biopsy (SLNB) is traditionally performed to determine the pathological lymph node (pN) status, to guide adjuvant treatment recommendations.[1] Results from landmark trials such as ACOSOG Z0011 demonstrated that cN0 patients treated with breast-conserving surgery (BCS) and whole breast radiation therapy (WBRT) who have limited sentinel lymph node(s) (SLN(s)) metastases, do not benefit from a completion axillary lymph node dissection (cALND).

Source: Radiotherapy and Oncology - December 21, 2023 Category: Radiology Authors: V.M. Wintraecken, L.J. Boersma, L.M. van Roozendaal, J. de Vries, S.M.J. van Kuijk, M.L.G. Vane, T. van Dalen, J.A. van der Hage, L.J.A. Strobbe, S.C. Linn, M.B.I. Lobbes, P.M.P Poortmans, V.C.G. Tjan-Heijnen, K.K.B.T. van de Vijver, A.H. Westenberg, J.H. Tags: Original Article Source Type: research